Assessing Novel Methods of Improving Patient Education of Nutrition
2 other identifiers
interventional
54
1 country
1
Brief Summary
The relationship between elevated phosphorus levels and morbidity and mortality in patients with chronic kidney disease (CKD) is well recognized, and dietary phosphorus restriction is a mainstay of phosphate management. Current study is an effort to test the effect of a web-based nutritional educational intervention, Kidney School(KS), to improve phosphorous knowledge and control phosphorous intake in CKD patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2006
CompletedFirst Posted
Study publicly available on registry
November 1, 2006
CompletedStudy Start
First participant enrolled
November 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedMay 6, 2019
May 1, 2019
2.6 years
October 30, 2006
May 1, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Gain in phosphorus knowledge as assessed by the chronic kidney disease Knowledge Assessment Tool (CKDKAT) of nutrition.
The CKDKAT of nutrition is a revised version of the original CKDKAT, which addresses only nutritional knowledge specific to chronic kidney disease (CKD). 15 of 25 questions are phosphorus-specific, with the remaining 10 concerning sodium, potassium and protein intake.
4 to 8 weeks post intial questionnaire/survey
Compliance with dietary phosphorous will be measured by serum phosphorous level.
Measurement of compliance with dietary phosphorous will be measured by serum phosphorous level. In CKD, Phosphorus excretion diminishes, leading to an increase in serum phosphorus levels.
4 to 8 weeks after initial questionnaire/survey appointment
Compliance with dietary phosphorous will be measured by serum calcium level
Measurement of compliance with dietary phosphorous will be measured by serum calcium level. In CKD, calcium is not reabsorbed, leading to decreased serum calcium.
4 to 8 weeks after initial questionaire/survey appointment
Compliance with dietary phosphorous will be measured by para thyroid hormone (PTH) level
Measurement of compliance with dietary phosphorous will be measured by para thyroid hormone (PTH) level. In CKD, Both decreased serum calcium levels and increased serum phosphorus levels stimulate excessive secretion of PTH.
4 to 8 weeks after initial questionnaire/survey appointment
Compliance with dietary phosphorous will be measured by serum calcium phosphorus product.
Measurement of compliance with dietary phosphorous will be measured by serum calcium phosphorus product.
4 to 8 weeks after initial questionnaire/survey appointment
Compliance with dietary phosphorus intake will be measured by using 24 hour recall diary.
For measuring compliance with dietary phosphorus intake, data will be collected by 24 hour recall diaries. Nutrient analysis data will be analyzed by Food Processor SQL Nutrition Software (ESHA Research, Salem, Oregon)
4 to 8 weeks after initial questionnaire/survey appointment
Secondary Outcomes (1)
Correlations between dietary phosphorus intake, serum phosphorous levels and circulating endothelial cells (CECs) in CKD
2 years
Study Arms (2)
usual care plus Internet-based nutrition module
EXPERIMENTALusual care plus Internet-based nutrition module
usual care
ACTIVE COMPARATORusual care
Interventions
usual care plus Internet-based nutrition module
Eligibility Criteria
You may qualify if:
- Age greater than or equal to 18 and less than 90
- Chronic kidney disease stage 3, 4 or 5
- Adequate visual acuity with correction to allow discrimination of 14-point type
- Ability to read English
- Ability to provide informed consent
You may not qualify if:
- Anticipated need for renal replacement therapy within 60 days
- Prison population
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UW Health Kidney Clinic and Wisconsin Dialysis
Madison, Wisconsin, 53713, United States
Related Publications (1)
Campbell ZC, Dawson JK, Kirkendall SM, McCaffery KJ, Jansen J, Campbell KL, Lee VW, Webster AC. Interventions for improving health literacy in people with chronic kidney disease. Cochrane Database Syst Rev. 2022 Dec 6;12(12):CD012026. doi: 10.1002/14651858.CD012026.pub2.
PMID: 36472416DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan B Jaffery, MD
School of Medicine and Public Health, University of Wisconsin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2006
First Posted
November 1, 2006
Study Start
November 1, 2006
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
May 6, 2019
Record last verified: 2019-05